We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.5B
AUM Growth
-$153M
Cap. Flow
-$237M
Cap. Flow %
-15.82%
Top 10 Hldgs %
44.48%
Holding
150
New
38
Increased
19
Reduced
36
Closed
39

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$69.6M
2
LRCX icon
Lam Research
LRCX
+$39.7M
3
TSM icon
TSMC
TSM
+$37.3M
4
STWD icon
Starwood Property Trust
STWD
+$21.4M
5
DOCS icon
Doximity
DOCS
+$21.2M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$41.8M
2
XOM icon
ExxonMobil
XOM
+$35M
3
RCL icon
Royal Caribbean
RCL
+$32.4M
4
CCL icon
Carnival Corporation Ltd
CCL
+$26.8M
5
TWLO icon
Twilio
TWLO
+$25M

Sector Composition

Rank Sector Weight
1 Healthcare 23.91%
2 Technology 23.09%
3 Consumer Discretionary 19.69%
4 Financials 18.86%
5 Miscellaneous 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCL icon
51
Royal Caribbean
RCL
$66.7B
$8.79M 0.59%
114,347
-399,200
-78% -$32.4M
TDOC icon
52
Teladoc Health
TDOC
$1.2B
$8.64M 0.58%
+94,050
New +$11.2M
GOOG icon
53
Alphabet (Google) Class C
GOOG
$4.18T
$8.57M 0.57%
59,260
-93,860
-61% -$13.6M
CCCC icon
54
C4 Therapeutics
CCCC
$422M
$8.23M 0.55%
255,681
-91,819
-26% -$3.63M
CRSP icon
55
CRISPR Therapeutics
CRSP
$5.01B
$8.03M 0.54%
106,007
-35,300
-25% -$3.08M
VCYT icon
56
Veracyte
VCYT
$3.23B
$7.57M 0.51%
183,660
-72,400
-28% -$3.2M
CCL icon
57
Carnival Corporation Ltd
CCL
$30.3B
$7.38M 0.49%
367,070
-1,251,870
-77% -$26.8M
APLS
58
DELISTED
Apellis Pharmaceuticals
APLS
$6.23M 0.42%
131,749
-6,000
-4% -$236K
PFE icon
59
Pfizer
PFE
$157B
$6.15M 0.41%
104,090
-303,900
-74% -$15.1M
CRSP icon
60
CALL
CRISPR Therapeutics
CRSP
$5.01B
$6.12M 0.41%
+80,800
New +$7.06M
V icon
61
Visa
V
$701B
$5.84M 0.39%
26,960
– –
PPH icon
62
VanEck Pharmaceutical ETF
PPH
$1B
$5.37M 0.36%
69,800
-23,300
-25% -$1.73M
ASHR icon
63
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.5B
$5.13M 0.34%
131,100
– –
HTZ icon
64
Hertz
HTZ
$688M
$4.97M 0.33%
+198,900
New +$4.76M
CSCO icon
65
Cisco
CSCO
$434B
$4.04M 0.27%
63,700
-732,000
-92% -$41.8M
BXSL icon
66
Blackstone Secured Lending
BXSL
$5.78B
$3.92M 0.26%
+115,305
New +$3.74M
CMPI
67
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$3.75M 0.25%
1,306,626
-260,700
-17% -$971K
NBXG
68
Neuberger Next Generation Connectivity Fund Inc
NBXG
$1.18B
$3.56M 0.24%
+205,700
New +$3.76M
HIE
69
DELISTED
Miller/Howard High Income Equity Fund
HIE
$3.38M 0.23%
327,704
+151,000
+85% +$1.54M
LLY icon
70
Eli Lilly
LLY
$1.01T
$3.32M 0.22%
12,013
– –
CHCT
71
Community Healthcare Trust
CHCT
$420M
$3.29M 0.22%
69,700
– –
GOF icon
72
Guggenheim Strategic Opportunities Fund
GOF
$1.93B
$2.92M 0.2%
+159,528
New +$3.05M
BTX
73
BlackRock Technology and Private Equity Term Trust
BTX
$987M
$2.77M 0.18%
+190,264
New +$3.15M
BRW
74
Saba Capital Income & Opportunities Fund
BRW
$319M
$2.52M 0.17%
279,094
-152,550
-35% -$1.4M
USA icon
75
Liberty All-Star Equity Fund
USA
$1.8B
$1.79M 0.12%
+213,952
New +$1.81M
1 2
3
4 5

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Clough Capital Partners held 150 positions worth $1.5B, down 9.3% from $1.65B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Clough Capital Partners withdrew a net $237M in Q4 2021, closing 39 positions and reducing 36 holdings. Its most notable exit was ExxonMobil, an estimated $35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Clough Capital Partners opened a new position in Micron Technology worth $83M.

  • Clough Capital Partners's largest Q4 2021 buy was Micron Technology: 891,300 shares worth $83M.
  • Clough Capital Partners added most to Merck in Q4 2021, an estimated $17.3M increase.
  • Clough Capital Partners's biggest Q4 2021 reduction was Cisco, cutting an estimated $41.8M.
  • Clough Capital Partners fully exited ExxonMobil in Q4 2021, selling an estimated $35M.
  • Clough Capital Partners's ten largest holdings make up 44% of its $1.5B portfolio in Q4 2021.
  • Clough Capital Partners opened 38 new positions and closed 39 in Q4 2021.
  • Clough Capital Partners's portfolio value fell 9.3% quarter-over-quarter to $1.5B.

Based on Clough Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.